Search Within

Maurizio Scaltriti

Formats
  1. Journal Article (94)
  2. Meeting Abstract (68)
  3. Book Section (3)
  4. Review (3)
  5. Guidelines (1)
  6. Research Letter (1)
Groups
  1. GSK Faculty (89)
  2. Sloan Kettering Institute Postdocs (86)
  3. Department of Medicine (80)
  4. Solid Tumor Oncology Division (79)
  5. Human Oncology and Pathogenesis Program (60)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (55)

More Groups

People
  1. Jose Baselga (63)
  2. Pedram Razavi (32)
  3. David Hyman (27)
  4. Michael Berger (27)
  5. Sarat Chandarlapaty (26)
  6. Emiliano Cocco (25)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (6)
  4. 2021 (16)
  5. 2020 (27)
  6. 2019 (26)

More Years

Publications
  1. Cancer Research (37)
  2. Annals of Oncology (16)
  3. Clinical Cancer Research (12)
  4. Cancer Discovery (8)
  5. Journal of Clinical Oncology (8)
  6. Cancer Cell (6)

More Publications

Publishers
  1. American Association for Cancer Research (59)
  2. Nature Publishing Group (20)
  3. Oxford University Press (17)
  4. Elsevier Inc. (12)
  5. American Association for the Advancement of Science (10)
  6. American Society of Clinical Oncology (9)

More Publishers

Results (170)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of NTRK fusions and therapeutic response to NTRK inhibition in hematologic malignancies
    Meeting Abstract

    Taylor, J.; Marcelus, C.; Pavlick, D.; Benayed, R.; Yoshimi, A.; Cocco, E.; Durham, B. H.; Hechtman, J. F.; Chung, Y. R.; Mullaney, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Targeting precision nanomedicines to the tumor microenvironment
    Meeting Abstract

    Heller, D.; Shamay, Y.; Haimovitz-Friedman, A.; Scaltriti, M.
    Abstracts of Papers of the American Chemical Society (2017)

    Fulltext@MSK | Save
  • Breast cancer genomics
    Book Section

    Scaltriti, M.
    In Veronesi, U.; Goldhirsch, A.; Veronesi, P.; Gentilini, O. D.; Leonardi, M. C. (Eds.) Breast Cancer: Innovations in Research and Management (2017)

    Fulltext@MSK | Save
  • Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases
    Journal Article

    Siravegna, G.; Geuna, E.; Mussolin, B.; Crisafulli, G.; Bartolini, A.; Galizia, D.; Casorzo, L.; Sarotto, I.; Scaltriti, M.; Sapino, A.; more...
    ESMO Open (2017)

    Fulltext@MSK | Save
  • Overcoming acquired resistance to PI3K inhibitors in head and neck squamous cell carcinoma with combination treatment
    Meeting Abstract

    Mizrachi, A.; Dunn, L.; Ho, A.; Scaltriti, M.
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • AGATA molecular screening program: Implementing precision medicine in patients with advanced breast cancer in Spain
    Meeting Abstract

    Simon, S. P.; Gonzalez, P. V.; Vivancos, A.; Prat, A.; Scaltriti, M.; Burgues, O.; Rodon, J.; Canes, J.; Lluch, A.; Llombart, A.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Genomic analyses reveal potential recurrence markers of locally advanced triple negative breast cancer treated by combined neoadjuvant EGFR targeting and chemotherapy
    Meeting Abstract

    Radosevic-Robin, N.; Cocco, E.; Won, H. H.; Berger, M. F.; Privat, M.; Abrial, C.; Penault-Llorca, F.; Scaltriti, M.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors
    Journal Article

    Drilon, A.; Nagasubramanian, R.; Blake, J. F.; Ku, N.; Tuch, B. B.; Ebata, K.; Smith, S.; Lauriault, V.; Kolakowski, G. R.; Brandhuber, B. J.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
    Journal Article

    Cook, P. J.; Thomas, R.; Kannan, R.; de Leon, E. S.; Drilon, A.; Rosenblum, M. K.; Scaltriti, M.; Benezra, R.; Ventura, A.
    Nature Communications (2017)

    Fulltext@MSK | Save
  • Methodologies for developing and maintaining patient-derived xenograft mouse models
    Book Section

    Mattar, M.; Abdel-Wahab, O.; Poirier, J. T.; Scaltriti, M.; de Stanchina, E.
    In Uthamanthil, R.; Tinkey, P.; de Stanchina, E. (Eds.) Patient Derived Tumor Xenograft Models: Promise, Potential and Practice (2017)

    Fulltext@MSK | Save